New study finds maternal vaccine and monoclonal antibody effective against RSV in infants Post author: Post published:January 10, 2024 Post category:uncategorized The impact and cost-effectiveness of maternal vaccination (MV) to long-acting monoclonal antibody (la-mAB) therapy. You Might Also Like Most hospital readmissions after heart failure are not heart-related July 8, 2026 Cap-QuIC: A new visual diagnostic technique for early detection of neurodegenerative diseases August 6, 2024 Thymus health in adults linked to longer life and disease risk March 18, 2026
Cap-QuIC: A new visual diagnostic technique for early detection of neurodegenerative diseases August 6, 2024